TITLE

Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X

AUTHOR(S)
A Di Monaco
PUB. DATE
April 2009
SOURCE
Heart;Apr2009, Vol. 95 Issue 7, p550
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To assess whether abnormalities in cardiac uptake of 123I-metaiodobenzylguanidine (MIBG) correlate with coronary microvascular dysfunction in patients with cardiac syndrome X (CSX). SETTING: University hospital. PATIENTS: 29 patients (aged 59 (SD 7) years, 11 men) with typical CSX and a matched group of 20 healthy subjects (aged 56 (7) years, 8 men) were studied. INTERVENTIONS: Planar and single photon emission computed tomography (SPECT) MIBG myocardial scintigraphy was performed in all subjects. Coronary flow response (CFR) to adenosine and to cold pressor test (CPT) in the left anterior descending (LAD) coronary artery was assessed in all CSX patients and in 12 controls by transthoracic Doppler echocardiography. MAIN OUTCOME MEASURES: Abnormalities in cardiac MIBG scintigraphy were observed in 25 CSX patients (86.2%), but in no healthy control (p<0.001). Compared to controls, CSX patients showed a lower heart/mediastinum (H/M) ratio of MIBG uptake (1.69 (0.24) vs 2.2 (0.3), p<0.001) and a higher cardiac MIBG defect score (25 (22) vs 4 (2), p = 0.002). Both CFR to adenosine (3.31 (1.1) vs 1.94 (0.6), p<0.001) and CFR to CPT (2.35 (0.5) vs 1.63 (0.4), p<0.001) were lower in CSX patients than in controls. In CSX patients, however, no correlation was found between MIBG H/M ratio and CFR to adenosine (r = 0.17; p = 0.38) and to CPT (r = –0.28; p = 0.13), as well as between MIBG uptake score in the LAD territory and CFR to adenosine (r = 0.14; p = 0.47) and to CPT (r = 0.06; p = 0.73). CONCLUSION: Our data show striking abnormalities in cardiac adrenergic nerve function and in coronary microvascular function in CSX patients. However, no significant relation between the two abnormalities was found. Further studies are needed to clarify the mechanisms and the role of MIBG defects in CSX patients.
ACCESSION #
36959864

 

Related Articles

  • LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME. Penjašković, Davor; Sakač, Dejan; Dejanović, Jovanka; Zec, Radovan; Zec-Petković, Nada; Stojšić-Milosavljević, Anastazija // Medicinski Pregled / Medical Review;Jan/Feb2012, Vol. 65 Issue 1/2, p18 

    Metabolic syndrome (MetS), which is a cluster of medical disorders, is common and it is associated with increased cardiovascular morbidity and mortality. The aim of this study was to evaluate the relationship between characteristics of metabolic syndrome and the grade of diastolic dysfunction....

  • BENEFIQ 2014...in Canada this fall.  // Nutraceuticals Now;Summer2014, p27 

    The article offers information on the BENEFIQ 2014 conference, International Rendezvous on Health Ingredients, to be held in Quebec City, Quebec on September 23-25, 2014 on topics including cardiovascular diseases, sports nutrition and metabolic syndrome.

  • Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals. Sekiguchi, Haruki; Shimamoto, Ken; Sekiguchi, Naoki; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background: Previous studies indicate that individuals with metabolic syndrome (MetS) might be at risk for left ventricular (LV) diastolic dysfunction. However, little is known about which metabolic factors contribute to the development of LV dysfunction in individuals who are not obese or...

  • Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Nan Hee Kim; Juri Park; Seong Hwan Kim; Yong Hyun Kim; Dong Hyuk Kim; Goo-Yeong Cho; Inkyung Baik; Hong Euy Lim; Eung Ju Kim; Jin Oh Na; Jung Bok Lee; Seung Ku Lee; Chol Shin // Heart;Jun2014, Vol. 100 Issue 12, p938 

    Objective The effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular system remains controversial. We investigated the independent contribution of NAFLD to cardiovascular structure and function in the general population. Methods A total of 1886 participants without known...

  • Why β-blockers are vital cardiovascular tools. Minhas, Rubin // Pulse;11/1/2004, Vol. 64 Issue 43, p44 

    Focuses on the role of β-blockers in cardiovascular disease medication. Efficacy in cardiovascular disease treatment; Effects of different classes of β-blockers; Adverse effects and contradictions; Considerations for clinical use. INSETS: The shifting ground on β-blockers;2 Summary of...

  • Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study. Faganello, Giorgio; Cioffi, Giovanni; Faggiano, Pompilio; Candido, Riccardo; Tarantini, Luigi; Feo, Stefania; Lenarda, Andrea; Simone, Giovanni // Acta Diabetologica;Feb2015, Vol. 52 Issue 1, p143 

    Patients with metabolic syndrome (MetS) have high cardiovascular event rates. The additional effect of MetS on left ventricular (LV) systolic function in patients with type 2 diabetes mellitus (T2DM) is unknown. We studied the relation between MetS and LV systolic function in T2DM patients...

  • Adolescents with metabolic syndrome have a history of low aerobic fitness and physical activity levels. McMurray, Robert G.; Bangdiwala, Shrikant I.; Harrell, Joanne S.; Amorim, Leila D. // Dynamic Medicine;2008, Vol. 7, Special section p1 

    Purpose: Metabolic syndrome (MS) is a clustering of cardiovascular disease risk factors that identifies individuals with the highest risk for heart disease. Two factors that may influence the MS are physical activity and aerobic fitness. This study determined if adolescent with the MS had low...

  • Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Nestel, Paul; Lyu, Ramon; Lip Ping Low; Sheu, Wayne Huey-Hernig; Nitiyanant, Wannee; Saito, Ikuo; Chee Eng Tan // Asia Pacific Journal of Clinical Nutrition;Jun2007, Vol. 16 Issue 2, p362 

    Background: The prevalence of the metabolic syndrome among a number of Asian populations as defined by several current criteria has been increasing rapidly and appears to resemble that among Western populations. Methods: We review 25 surveys of the metabolic syndrome in Asian populations (PR...

  • The Prevalence of the Metabolic Syndrome in Korean Children and Adolescents: Comparisons of the Criteria of Cook et al., Cruz and Goran, and Ferranti et al. Su Jin Seo; Hyo Young Lee; Seung Wook Lee // Yonsei Medical Journal;8/30/2008, Vol. 49 Issue 4, p563 

    Purpose: Although the metabolic syndrome (MS), which can lead to the development of cardiovascular disease (CVD) or diabetes mellitus (DM), is increasing in children and adolescents, no unified criteria have been established, and little attention has been paid to its occurrence in Korean...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics